Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1975 Mar 1;141(3):697–702. doi: 10.1084/jem.141.3.697

Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses

PMCID: PMC2189708  PMID: 1117258

Abstract

Mice immunized with more SRBC than are required to produce optimal delayed-type hypersensitivity reactions, developed good antibody responses and poor delayed foot pad reactions. Cyclophosphamide treatment in low doses (20 mg/kg) before immunization, augmented the delayed-type hypersensitivity without affecting antibody responses. Cyclophosphamide did not augment delayed responses to optimal doses of SRBC (0.01%), but did augment the delayed hypersensitivity response of mice immunized with a suboptimal antigen dose (0.001%); which produced no detectable antibody response with or without cyclophosphamide pretreatment. These results suggest that antibody feedback is not the sole regulator of delayed reactions; the possibility that suppressor T cells may also be involved is discussed.

Full Text

The Full Text of this article is available as a PDF (364.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BENACERRAF B., GELL P. G. Studies on hypersensitivity. I. Delayed and Arthustype skin reactivity to protein conjugates in guinea pigs. Immunology. 1959 Jan;2(1):53–63. [PMC free article] [PubMed] [Google Scholar]
  2. Dennert G., Tucker D. F. Selective priming of T cells by chemically altered cell antigens. J Exp Med. 1972 Sep 1;136(3):656–661. doi: 10.1084/jem.136.3.656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gershon R. K., Mokyr M. B., Mitchell M. S. Activation of suppressor T cells by tumour cells and specific antibody. Nature. 1974 Aug 16;250(467):594–596. doi: 10.1038/250594a0. [DOI] [PubMed] [Google Scholar]
  4. Katz S. I., Parker D., Sommer G., Turk J. L. Suppressor cells in normal immunisation as a basic homeostatic phenomenon. Nature. 1974 Apr 12;248(449):612–614. doi: 10.1038/248612a0. [DOI] [PubMed] [Google Scholar]
  5. Kettman J. Delayed hypersensitivity: is the same population of thymus-derived cells responsible for cellular immunity reactions and the carrier effect? Immunol Commun. 1972;1(3):289–299. doi: 10.3109/08820137209022942. [DOI] [PubMed] [Google Scholar]
  6. Lagrange P. H., Mackaness G. B., Miller T. E. Influence of dose and route of antigen injection on the immunological induction of T cells. J Exp Med. 1974 Mar 1;139(3):528–542. doi: 10.1084/jem.139.3.528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lagrange P. H., Mackaness G. B., Miller T. E. Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J Exp Med. 1974 Jun 1;139(6):1529–1539. doi: 10.1084/jem.139.6.1529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Mackaness G. B., Lagrange P. H., Miller T. E., Ishibashi T. Feedback inhibition of specifically sensitized lymphocytes. J Exp Med. 1974 Mar 1;139(3):543–559. doi: 10.1084/jem.139.3.543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Moorhead J. W., Claman H. N. Subpopulations of mouse T lymphocytes. I. "Thymidine suicide" of a major proliferating, PHA-responsive cell population present in spleen but not in lymph node. J Immunol. 1974 Jan;112(1):333–338. [PubMed] [Google Scholar]
  10. Parish C. R. Immune response to chemically modified flagellin. II. Evidence for a fundamental relationship between humoral and cell-mediated immunity. J Exp Med. 1971 Jul 1;134(1):21–47. doi: 10.1084/jem.134.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Parish C. R. Preferential induction of cell-mediated immunity by chemically modified sheep erythrocytes. Eur J Immunol. 1972 Apr;2(2):143–151. doi: 10.1002/eji.1830020210. [DOI] [PubMed] [Google Scholar]
  12. Pearson M. N., Raffel S. Macrophage-digested antigen as inducer of delayed hypersensitivity. J Exp Med. 1971 Mar 1;133(3):494–505. doi: 10.1084/jem.133.3.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Polak L., Turk J. L. Reversal of immunological tolerance by cyclophosphamide through inhibition of suppressor cell activity. Nature. 1974 Jun 14;249(458):654–656. doi: 10.1038/249654a0. [DOI] [PubMed] [Google Scholar]
  14. Turk J. L., Parker D. Further studies on B-lymphocyte suppression in delayed hypersensitivity, indicating a possible mechanism for Jones-Mote hypersensitivity. Immunology. 1973 Apr;24(4):751–758. [PMC free article] [PubMed] [Google Scholar]
  15. Turk J. L., Parker D., Poulter L. W. Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide. Immunology. 1972 Oct;23(4):493–501. [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES